Another advantage of our approach is the evolutionarily conserved effects of 5-FU on host metabolism, at similar physiological drug concentrations to that observed in human plasma after treatment or at concentrations capable of inhibiting TS in colon cancer cells (Ser et al., 2016). Here, TYMS is linked to malignant colon neoplasm.